Washington D.C., Nov 1, 2022 / 18:00 pm
The Food and Drug Administration (FDA) is warning about the dangers of health professionals prescribing an abortion drug to women before they are pregnant, after it had previously loosened restrictions on the drug.
Some abortion providers are participating in “advance provision” of these abortion drugs in response to state abortion restrictions following the Supreme Court’s recent decision to overturn Roe v. Wade.
“The FDA is concerned about the advance prescribing of mifepristone for this use,” an FDA spokesperson told Politico on Friday. “Mifepristone is not approved for advance provision of a medical abortion.”
The agency’s comments come after it lifted restrictions on mifepristone distribution in December. The decision authorized doctors to prescribe the drugs online and mail the pills, allowing pregnant women to perform early abortions without leaving their homes.